Evidence map›Paper›PMID 27542231›Full record

ArticleOncotarget2016

Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells.

Federica Baldan, Catia Mio, Lorenzo Allegri, Ketty Conzatti, Barbara Toffoletto, Cinzia Puppin, Slobodanka Radovic, Carlo Vascotto, Diego Russo, Carla Di Loreto and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Federica BaldanDepartment of Medical and Biological Sciences, University of Udine, 33100 Udine, Italy.
Catia MioDepartment of Medical and Biological Sciences, University of Udine, 33100 Udine, Italy.
Lorenzo AllegriDepartment of Medical and Biological Sciences, University of Udine, 33100 Udine, Italy.
Ketty ConzattiDepartment of Medical and Biological Sciences, University of Udine, 33100 Udine, Italy.
Barbara ToffolettoDepartment of Medical and Biological Sciences, University of Udine, 33100 Udine, Italy.
Cinzia PuppinDepartment of Medical and Biological Sciences, University of Udine, 33100 Udine, Italy.
Slobodanka RadovicIGA Technology Services Srl, 33100 Udine, Italy.
Carlo VascottoDepartment of Medical and Biological Sciences, University of Udine, 33100 Udine, Italy.
Diego RussoDepartment of Health Sciences, University of Catanzaro "Magna Graecia", 88100 Catanzaro, Italy.
Carla Di LoretoDepartment of Medical and Biological Sciences, University of Udine, 33100 Udine, Italy.
Giuseppe DamanteDepartment of Medical and Biological Sciences, University of Udine, 33100 Udine, Italy.
University of Udine · ITIstituto di Genomica Applicata · ITMagna Graecia University · ITOspedale Santa Maria della Misericordia di Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA binding proteins (RBPs) play a central role in cell physiology and pathology. Among them, HuR is a nuclear RBP, which shuttles to the cytoplasm to allow its RNA targets processing. HuR over-expression and delocalization are often associated to cell transformation. Numerous cancers display increased HuR protein levels and its high cytoplasmic levels has been associated with a worse prognosis.In our study, we first evaluated HuR expression in normal and cancer thyroid tissues and then evaluated its function in thyroid cell lines. HuR is over-expressed in all thyroid tumor tissues; high cytoplasmic levels are detected in all thyroid carcinomas. HuR silencing decreased cell viability and determined apoptotic cell death, in a non-tumorigenic (Nthy-ori-3.1) and a tumorigenic (BCPAP) thyroid cell line. Global transcriptome analysis indicated that HuR silencing, though having similar biological effects, induces distinct gene expression modifications in the two cell lines. By using the RIP-seq approach, the HuR-bound RNA profiles of different thyroid cell lines were evaluated. We show that in distinct cell lines HuR-bound RNA profiles are different. A set of 114 HuR-bound RNAs distinguishing tumorigenic cell lines from the non-tumorigenic one was identified.Altogether, our data indicate that HuR plays a role in thyroid tumorigenesis. Moreover, our findings are a proof of concept that RBP targets differ between cells with the same origin but with distinct biological behavior.

Indexed as

AdenomaApoptosisBiomarkers, TumorCarcinogenesisCarcinoma, PapillaryCell ProliferationELAV-Like Protein 1Gene Expression ProfilingGene Expression Regulation, NeoplasticHumansNeoplasm InvasivenessPrognosisRNA-Binding ProteinsRNA, MessengerSurvival RateThyroid Cancer, PapillaryBiomarkers, TumorELAVL1 protein, humanELAV-Like Protein 1RNA-Binding ProteinsRNA, MessengerHuRRIP-seqRNA-binding proteinsRNA-seq

Identifiers

PMID27542231
PMCPMC5325372
OpenAlexW2515707345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.